APT MEDICAL INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 493.7 CNY | +4.17% |
|
+8.59% | +27.07% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 18,668 | 20,463 | 25,854 | 32,854 | - | - |
| Enterprise Value (EV) 1 | 18,668 | 20,463 | 25,854 | 32,854 | 32,854 | 32,854 |
| P/E ratio | 88.3 x | 57.9 x | 49.1 x | 50.9 x | 36.9 x | 29.7 x |
| Yield | 0.36% | 0.54% | 0.51% | 0.62% | 0.86% | - |
| Capitalization / Revenue | 22.5 x | 16.8 x | 15.7 x | 14.9 x | 11.1 x | 8.7 x |
| EV / Revenue | 22.5 x | 16.8 x | 15.7 x | 14.9 x | 11.1 x | 8.7 x |
| EV / EBITDA | 74.2 x | 46.4 x | 39.2 x | 38.3 x | 28.3 x | 22.3 x |
| EV / FCF | 1,328,964,108 x | 91,157,838 x | - | - | - | - |
| FCF Yield | 0% | 0% | - | - | - | - |
| Price to Book | 10.5 x | 11.6 x | 13.6 x | 14.6 x | 10.5 x | 8.34 x |
| Nbr of stocks (in thousands) | 66,670 | 66,670 | 66,550 | 66,550 | - | - |
| Reference price 2 | 280.0 | 306.9 | 388.5 | 493.7 | 493.7 | 493.7 |
| Announcement Date | 2/24/22 | 2/23/23 | 2/23/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 479.4 | 828.7 | 1,216 | 1,650 | 2,202 | 2,963 | 3,776 |
| EBITDA 1 | - | 251.4 | 440.9 | 659.5 | 856.7 | 1,160 | 1,473 |
| EBIT 1 | 119.4 | 222.5 | 397 | 600.4 | 772.9 | 1,068 | 1,375 |
| Operating Margin | 24.91% | 26.85% | 32.65% | 36.38% | 35.1% | 36.04% | 36.41% |
| Earnings before Tax (EBT) 1 | 121.2 | 221.6 | 395.1 | 596.4 | 771.9 | 1,067 | 1,374 |
| Net income 1 | 110.8 | 207.9 | 358 | 533.9 | 698 | 948.9 | 1,240 |
| Net margin | 23.11% | 25.09% | 29.44% | 32.35% | 31.7% | 32.03% | 32.83% |
| EPS 2 | 2.220 | 3.170 | 5.300 | 7.920 | 9.690 | 13.36 | 16.63 |
| Free Cash Flow | - | 14.05 | 224.5 | - | - | - | - |
| FCF margin | - | 1.7% | 18.46% | - | - | - | - |
| FCF Conversion (EBITDA) | - | 5.59% | 50.91% | - | - | - | - |
| FCF Conversion (Net income) | - | 6.76% | 62.7% | - | - | - | - |
| Dividend per Share 2 | - | 1.000 | 1.650 | 2.000 | 3.060 | 4.250 | - |
| Announcement Date | 2/24/21 | 2/24/22 | 2/23/23 | 2/23/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | 14 | 224 | - | - | - | - |
| ROE (net income / shareholders' equity) | 27.4% | 18.4% | 20.1% | 30.2% | 27.8% | 29.6% | 28.3% |
| ROA (Net income/ Total Assets) | - | 15.9% | 16.9% | 22.2% | 20.9% | 23.4% | 19.6% |
| Assets 1 | - | 1,309 | 2,120 | 2,404 | 3,348 | 4,061 | 6,326 |
| Book Value Per Share 2 | 9.210 | 26.70 | 26.40 | 28.50 | 33.80 | 47.00 | 59.20 |
| Cash Flow per Share 2 | 2.960 | 2.770 | 5.510 | 10.30 | 7.620 | 16.00 | 12.50 |
| Capex 1 | - | 167 | 143 | 189 | 124 | 142 | 135 |
| Capex / Sales | - | 20.19% | 11.76% | 11.48% | 5.62% | 4.78% | 3.57% |
| Announcement Date | 2/24/21 | 2/24/22 | 2/23/23 | 2/23/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
493.7
CNY
Average target price
450.4
CNY
Spread / Average Target
-8.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +27.07% | 4.53B | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +4.81% | 5.84B | |
| +5.99% | 5.01B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.49% | 2.02B | |
| +5.07% | 1.88B |
- Stock Market
- Equities
- 688617 Stock
- Financials APT Medical Inc.
